Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NOS2 inhibitors(Nitric oxide synthase, inducible inhibitors), nNOS inhibitors(Nitric-oxide synthase, brain inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H15F2N5O |
InChIKeyISGGXCWQSOCOCW-UHFFFAOYSA-N |
CAS Registry1125746-49-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | 29 Oct 2010 | |
Pain | Preclinical | US | 29 Oct 2010 |